Gemin X Pharmaceuticals, Inc.

H.I.G. Capital, a global private equity firm with more than $8.5 billion under management, has closed its second life sciences-focused venture fund - H.I.G. BioVentures II – at $268 million, exceeding

Iconoclastic investor Peter Thiel famously has offered smart young people money not to go to college. Now his personal foundation, through a venture called Breakout Labs , wants to play a role usuall

H.I.G. Capital , a private investment firm with over $8.5 billion under management, announced the closing of its second life sciences fund, H.I.G. BioVentures II, on April 10th. The diversified life s

Genta has finally put an end to the long and troubled development of its investigational antisense therapy Genasense for melanoma. While Harold Camping is just the latest in a series of false prophets